It is tempting to speculate that a finely tuned balance of the opposing actions of aTGFβ and exogenous TGFβ1 does not only control invasion and proliferation, but by inducing a partial/hybrid EMT also generates cancer stem cells and promotes resistance to anti-cancer drugs [55,56]. The gene discussed is TGFB1; the disease is cancer.